{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:29:25Z","timestamp":1790882965891,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,7,28]],"date-time":"2011-07-28T00:00:00Z","timestamp":1311811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,7,28]],"date-time":"2011-07-28T00:00:00Z","timestamp":1311811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1038\/jhg.2011.80","type":"journal-article","created":{"date-parts":[[2011,7,28]],"date-time":"2011-07-28T06:21:39Z","timestamp":1311834099000},"page":"676-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease"],"prefix":"10.1038","volume":"56","author":[{"given":"Ana M","family":"Peir\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren M","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rassenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A","family":"Insel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,28]]},"reference":[{"key":"BFjhg201180_CR1","first-page":"725","volume":"75","author":"JA Beavo","year":"1995","unstructured":"Beavo, J. A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Phys. Rev. 75, 725 (1995).","journal-title":"Phys. Rev."},{"key":"BFjhg201180_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","volume":"76","author":"M Conti","year":"2007","unstructured":"Conti, M. & Beavo, J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu. Rev. Biochem. 76, 481\u2013511 (2007).","journal-title":"Annu. Rev. Biochem."},{"key":"BFjhg201180_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF00915791","volume":"3","author":"JS Goodwin","year":"1983","unstructured":"Goodwin, J. S. & Ceuppens, J. Regulation of the immune response by prostaglandins. J. Clin. Immunol. 3, 295\u2013315 (1983).","journal-title":"J. Clin. Immunol."},{"key":"BFjhg201180_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2249.1995.tb03123.x","volume":"101","author":"AR Moore","year":"1995","unstructured":"Moore, A. R. & Willoughby, D. A. The role of cAMP regulation in controlling inflammation. Clin. Exp. Immunol. 101, 387 (1995).","journal-title":"Clin. Exp. Immunol."},{"key":"BFjhg201180_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1096-7192(03)00035-0","volume":"79","author":"H Osawa","year":"2003","unstructured":"Osawa, H., Niiya, T., Onuma, H., Murakami, A., Ochi, M., Nishimiya, T. et al. Others systematic search for single nucleotide polymorphisms in the 5\u2032 flanking region of the human phosphodiesterase 3B gene: absence of evidence for major effects of identified polymorphisms on susceptibility to Japanese type 2 diabetes. Mol. Genet. Metab. 79, 43\u201351 (2003).","journal-title":"Mol. Genet. Metab."},{"key":"BFjhg201180_CR6","doi-asserted-by":"publisher","first-page":"14771","DOI":"10.1073\/pnas.0506489102","volume":"102","author":"B Ding","year":"2005","unstructured":"Ding, B., Abe, J., Wei, H., Xu, H., Che, W., Aizawa, T. et al. A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. Proc. Natl. Acad. Sci. USA 102, 14771 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFjhg201180_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1042\/bj3210165","volume":"321","author":"S Erdogan","year":"1997","unstructured":"Erdogan, S. & Houslay, M. D. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A. Biochem. J. 321, 165 (1997).","journal-title":"Biochem. J."},{"key":"BFjhg201180_CR8","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.cellsig.2008.07.017","volume":"20","author":"A McCahill","year":"2008","unstructured":"McCahill, A., Campbell, L., McSorley, T., Sood, A., Lynch, M. J., Li, X. et al. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10). Cell Signal 20, 2071\u20132083 (2008).","journal-title":"Cell Signal"},{"key":"BFjhg201180_CR9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0026-895X(25)08757-7","volume":"47","author":"MW Verghese","year":"1995","unstructured":"Verghese, M. W., McConnell, R. T., Lenhard, J. M., Hamacher, L. & Jin, S. L. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Mol. Pharmacol. 47, 1164 (1995).","journal-title":"Mol. Pharmacol."},{"key":"BFjhg201180_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bcp.2004.09.012","volume":"69","author":"M Ahlstr\u00f6m","year":"2005","unstructured":"Ahlstr\u00f6m, M., Pekkinen, M., Huttunen, M. & Lamberg-Allardt, C. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells. Biochem. Pharmacol. 69, 267\u2013275 (2005).","journal-title":"Biochem. Pharmacol."},{"key":"BFjhg201180_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0898-6568(99)00039-X","volume":"11","author":"T Hermsdorf","year":"1999","unstructured":"Hermsdorf, T., Richter, W. & Dettmer, D. Effects of dexamethasone and glucagon after long-term exposure on cyclic AMP phosphodiesterase 4 in cultured rat hepatocytes. Cell. Signal. 11, 685\u2013690 (1999).","journal-title":"Cell. Signal."},{"key":"BFjhg201180_CR12","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1182\/blood-2004-01-0341","volume":"104","author":"LR Goldin","year":"2004","unstructured":"Goldin, L. R., Pfeiffer, R. M., Li, X. & Hemminki, K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish family-cancer database. Blood 104, 1850 (2004).","journal-title":"Blood"},{"key":"BFjhg201180_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1006\/bbrc.2000.2743","volume":"272","author":"C Gardner","year":"2000","unstructured":"Gardner, C., Robas, N., Cawkill, D. & Fidock, M. Cloning and characterization of the human and mouse PDE7B, a novel cAMP-specific cyclic nucleotide phosphodiesterase. Biochem. Biophys. Res. Commun. 272, 186\u2013192 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFjhg201180_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1073\/pnas.97.1.472","volume":"97","author":"JM Hetman","year":"2000","unstructured":"Hetman, J. M., Soderling, S. H., Glavas, N. A. & Beavo, J. A. Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase. Proc. Natl. Acad. Sci. USA 97, 472 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFjhg201180_CR15","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.283.5403.848","volume":"283","author":"L Li","year":"1999","unstructured":"Li, L., Yee, C. & Beavo, J. A. CD3- and CD28-dependent induction of PDE7 required for T cell activation. Science 283, 848\u2013851 (1999).","journal-title":"Science"},{"key":"BFjhg201180_CR16","doi-asserted-by":"publisher","first-page":"19532","DOI":"10.1073\/pnas.0806152105","volume":"105","author":"L Zhang","year":"2008","unstructured":"Zhang, L., Murray, F., Zahno, A., Kanter, J. R., Chou, D., Suda, R. et al. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 105, 19532\u201319537 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFjhg201180_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.schres.2008.01.029","volume":"101","author":"SH Fatemi","year":"2008","unstructured":"Fatemi, S. H., King, D. P., Reutiman, T. J., Folsom, T. D., Laurence, J. A., Lee, S. et al. PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia. Schizophr. Res. 101, 36\u201349 (2008).","journal-title":"Schizophr. Res."},{"key":"BFjhg201180_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jpsychires.2008.01.013","volume":"43","author":"S Numata","year":"2008","unstructured":"Numata, S., Ueno, S. I., Iga, J. I., Song, H., Nakataki, M., Tayoshi, S. et al. Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population. J. Psychiatr. Res. 43, 7\u201312 (2008).","journal-title":"J. Psychiatr. Res."},{"key":"BFjhg201180_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/YPG.0b013e328014492b","volume":"17","author":"BS Pickard","year":"2007","unstructured":"Pickard, B. S., Thomson, P. A., Christoforou, A., Evans, K. L., Morris, S. W., Porteous, D. J. et al. The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr. Genet. 17, 129 (2007).","journal-title":"Psychiatr. Genet."},{"key":"BFjhg201180_CR20","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.2174\/092986707782793871","volume":"14","author":"T Nakayama","year":"2007","unstructured":"Nakayama, T., Asai, S., Sato, N. & Soma, M. PDE4D gene in the STRK1 region on 5q12: susceptibility gene for ischemic stroke. Curr. Med. Chem. 14, 3171\u20133178 (2007).","journal-title":"Curr. Med. Chem."},{"key":"BFjhg201180_CR21","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong, D. T., Berson, E. L. & Dryja, T. P. Retinitis pigmentosa. Lancet 368, 1795\u20131809 (2006).","journal-title":"Lancet"},{"key":"BFjhg201180_CR22","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","volume":"87","author":"BD Cheson","year":"1996","unstructured":"Cheson, B. D., Bennett, J. M., Grever, M., Kay, N., Keating, M. J., OBrien, S. et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87, 4990\u20134997 (1996).","journal-title":"Blood"},{"key":"BFjhg201180_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.beha.2007.04.001","volume":"20","author":"TJ Kipps","year":"2007","unstructured":"Kipps, T. J. The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia. Best Pract. Res. Clin. Haematol. 20, 415\u2013424 (2007).","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"BFjhg201180_CR24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa040857","volume":"351","author":"LZ Rassenti","year":"2004","unstructured":"Rassenti, L. Z., Huynh, L., Toy, T. L., Chen, L., Keating, M. J., Gribben, J. G. et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N. Engl. J. Med. 351, 893\u2013901 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg201180_CR25","doi-asserted-by":"publisher","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","volume":"101","author":"A Wiestner","year":"2003","unstructured":"Wiestner, A., Rosenwald, A., Barry, T. S., Wright, G., Davis, R. E., Henrickson, S. E. et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101, 4944 (2003).","journal-title":"Blood"},{"key":"BFjhg201180_CR26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.yexmp.2007.08.009","volume":"83","author":"JM Cruse","year":"2007","unstructured":"Cruse, J. M., Lewis, R. E., Webb, R. N., Sanders, C. M. & Suggs, J. L. Zap-70 and CD38 as predictors of IgVH mutation in CLL. Exp. Mol. Pathol. 83, 459\u2013461 (2007).","journal-title":"Exp. Mol. Pathol."},{"key":"BFjhg201180_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.blre.2008.03.003","volume":"22","author":"C Moreno","year":"2008","unstructured":"Moreno, C. & Montserrat, E. New prognostic markers in chronic lymphocytic leukemia. Blood Rev. 22, 211\u2013219 (2008).","journal-title":"Blood Rev."},{"key":"BFjhg201180_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1634\/theoncologist.11-1-21","volume":"11","author":"BL Abbott","year":"2006","unstructured":"Abbott, B. L. Chronic lymphocytic leukemia: recent advances in diagnosis and treatment. Oncologist 11, 21 (2006).","journal-title":"Oncologist"},{"key":"BFjhg201180_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.critrevonc.2007.04.008","volume":"64","author":"P Ghia","year":"2007","unstructured":"Ghia, P., Ferreri, A. J. M. & Caligaris-Cappio, F Chronic lymphocytic leukemia. Crit. Rev. Oncol. Hematol. 64, 234\u2013246 (2007).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"BFjhg201180_CR30","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1158\/0008-5472.CAN-09-3139","volume":"70","author":"EV Abel","year":"2010","unstructured":"Abel, E. V. & Aplin, A. E. FOXD3 is a mutant B-RAF-regulated inhibitor of G1-S progression in melanoma cells. Cancer Res. 70, 2891 (2010).","journal-title":"Cancer Res."},{"key":"BFjhg201180_CR31","doi-asserted-by":"publisher","first-page":"23126","DOI":"10.1074\/jbc.271.38.23126","volume":"271","author":"J Sutton","year":"1996","unstructured":"Sutton, J., Costa, R., Klug, M., Field, L., Xu, D., Largaespada, D. A. et al. Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells. J. Biol. Chem. 271, 23126 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFjhg201180_CR32","doi-asserted-by":"publisher","first-page":"13433","DOI":"10.1073\/pnas.0906455106","volume":"106","author":"SS Chen","year":"2009","unstructured":"Chen, S. S., Raval, A., Johnson, A. J., Hertlein, E., Liu, T. H., Jin, V. X. et al. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 106, 13433 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFjhg201180_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/FPC.0b013e328320a3e2","volume":"19","author":"M Cabanero","year":"2009","unstructured":"Cabanero, M., Laje, G., Detera-Wadleigh, S. & McMahon, F. J. Association Study of Phosphodiesterase Genes in the Sequenced Alternatives to Relieve Depression (STAR* D) sample. Pharmacogenet. Genomics 19, 235 (2009).","journal-title":"Pharmacogenet. Genomics"},{"key":"BFjhg201180_CR34","doi-asserted-by":"publisher","first-page":"15124","DOI":"10.1073\/pnas.0602795103","volume":"103","author":"ML Wong","year":"2006","unstructured":"Wong, M. L., Whelan, F., Deloukas, P., Whittaker, P., Delgado, M., Cantor, R. M. et al. Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response. Proc. Natl. Acad. Sci. USA 103, 15124 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFjhg201180_CR35","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/sj.mp.4002074","volume":"12","author":"KS Teranishi","year":"2007","unstructured":"Teranishi, K. S., Slager, S. L., Garriock, H., Kraft, J. B., Peters, E. J., Reinalda, M. S. et al. Variants in PDE11A and PDE1A are not associated with citalopram response. Mol. Psychiatry 12, 1061\u20131063 (2007).","journal-title":"Mol. Psychiatry"},{"key":"BFjhg201180_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/sj.ijir.3901246","volume":"16","author":"F Salvi","year":"2004","unstructured":"Salvi, F., Sarzani, R., Giorgi, R., Donatelli, G., Pietrucci, F., Micheli, A. et al. Cardiovascular effects of sildenafil in hypertensive men with erectile dysfunction and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5). Int. J. Impot. Res. 16, 412\u2013417 (2004).","journal-title":"Int. J. Impot. Res."},{"key":"BFjhg201180_CR37","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/ijc.25785","volume":"129","author":"L Zhang","year":"2011","unstructured":"Zhang, L., Murray, F., Rassenti, L. Z., Pu, M., Kelly, C., Kanter, J. R. et al. Cyclic nucleotide phosphodiesterase 7B mRNA: an unfavorable characteristic in chronic lymphocytic leukemia. Int. J. Cancer 129, 1162\u20131169 (2011).","journal-title":"Int. J. Cancer"},{"key":"BFjhg201180_CR38","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nature06742","volume":"451","author":"M Jakobsson","year":"2008","unstructured":"Jakobsson, M., Scholz, S. W., Scheet, P., Gibbs, J. R., VanLiere, J. M., Fung, H. C. et al. Genotype, haplotype and copy-number variation in worldwide human populations. Nature 451, 998\u20131003 (2008).","journal-title":"Nature"},{"key":"BFjhg201180_CR39","doi-asserted-by":"publisher","first-page":"R168","DOI":"10.1093\/hmg\/ddm241","volume":"16","author":"D Pinto","year":"2007","unstructured":"Pinto, D., Marshall, C., Feuk, L. & Scherer, S. W. Copy-number variation in control population cohorts. Hum. Mol. Genet. 16, R168 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg201180_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000095923","volume":"115","author":"EK Cho","year":"2006","unstructured":"Cho, E. K., Tchinda, J., Freeman, J. L., Chung, Y. J., Cai, W. W. & Lee, C. Array-based comparative genomic hybridization and copy number variation in cancer research. Cytogenet. Genome Res. 115, 262\u2013272 (2006).","journal-title":"Cytogenet. Genome Res."},{"key":"BFjhg201180_CR41","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1038\/ng2080","volume":"39","author":"SA McCarroll","year":"2007","unstructured":"McCarroll, S. A. & Altshuler, D. M. Copy-number variation and association studies of human disease. Nat. Genet. 39, S37\u2013S42 (2007).","journal-title":"Nat. Genet."},{"key":"BFjhg201180_CR42","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/GIM.0b013e318149e1e3","volume":"9","author":"L Rodriguez-Revenga","year":"2007","unstructured":"Rodriguez-Revenga, L., Mila, M., Rosenberg, C., Lamb, A. & Lee, C. Structural variation in the human genome: the impact of copy number variants on clinical diagnosis. Genet. Med. 9, 600 (2007).","journal-title":"Genet. Med."},{"key":"BFjhg201180_CR43","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.1136678","volume":"315","author":"BE Stranger","year":"2007","unstructured":"Stranger, B. E., Forrest, M. S., Dunning, M., Ingle, C. E., Beazley, C., Thorne, N. et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848 (2007).","journal-title":"Science"},{"key":"BFjhg201180_CR44","first-page":"216","volume":"157","author":"SP Nana-Sinkam","year":"2011","unstructured":"Nana-Sinkam, S. P. & Croce, C. M. MicroRNAs as therapeutic targets in cancer. J. Lab. Clin. Med. 157, 216\u2013225 (2011).","journal-title":"J. Lab. Clin. Med."},{"key":"BFjhg201180_CR45","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1182\/blood-2008-05-158865","volume":"113","author":"V Grubor","year":"2009","unstructured":"Grubor, V., Krasnitz, A., Troge, J. E., Meth, J. L., Lakshmi, B., Kendall, J. T. et al. Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA). Blood 113, 1294 (2009).","journal-title":"Blood"},{"key":"BFjhg201180_CR46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/72785","volume":"24","author":"JF Costello","year":"2000","unstructured":"Costello, J. F., Fr\u00fchwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 24, 132\u2013138 (2000).","journal-title":"Nat. Genet."},{"key":"BFjhg201180_CR47","first-page":"135","volume":"249","author":"M L\u00fcbbert","year":"2000","unstructured":"L\u00fcbbert, M. DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action. Curr. Top. Microbiol. Immunol. 249, 135 (2000).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFjhg201180_CR48","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cell.2007.03.043","volume":"129","author":"A Raval","year":"2007","unstructured":"Raval, A., Tanner, S. M., Byrd, J. C., Angerman, E. B., Perko, J. D., Chen, S. S. et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129, 879\u2013890 (2007).","journal-title":"Cell"},{"key":"BFjhg201180_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neulet.2004.09.037","volume":"372","author":"R Rabionet","year":"2004","unstructured":"Rabionet, R., Jaworski, J. M., Ashley-Koch, A. E., Martin, E. R., Sutcliffe, J. S., Haines, J. L. et al. Analysis of the autism chromosome 2 linkage region: GAD1 and other candidate genes. Neurosci. Lett. 372, 209\u2013214 (2004).","journal-title":"Neurosci. Lett."},{"key":"BFjhg201180_CR50","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1540-8167.2007.00913.x","volume":"18","author":"ZA Bhuiyan","year":"2007","unstructured":"Bhuiyan, Z. A., Hamdan, M. A., SHAMSI, E. T. A., Postma, A. V., Mannens, M.M.A.M., WILDE, A. A. M. et al. A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22. J. Cardiovasc. Electrophysiol. 18, 1060\u20131066 (2007).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFjhg201180_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0168-8227(01)00287-X","volume":"54","author":"R Sano","year":"2001","unstructured":"Sano, R., Miki, T., Suzuki, Y., Shimada, F., Taira, M., Kanatsuka, A. et al. Analysis of the insulin-sensitive phosphodiesterase 3B gene in type 2 diabetes. Diabetes Res. Clin. Pract. 54, 79\u201388 (2001).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFjhg201180_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.schres.2009.06.019","volume":"114","author":"A Rastogi","year":"2009","unstructured":"Rastogi, A., Zai, C., Likhodi, O., Kennedy, J. L. & Wong, A. H. Genetic association and post-mortem brain mRNA analysis of DISC1 and related genes in schizophrenia. Schizophr. Res. 114, 39\u201349 (2009).","journal-title":"Schizophr. Res."},{"key":"BFjhg201180_CR53","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1747-4949.2008.00199.x","volume":"3","author":"A Munshi","year":"2008","unstructured":"Munshi, A. & Kaul, S. Stroke genetics\u2013focus on PDE4D gene. Int. J. Stroke 3, 188\u2013192 (2008).","journal-title":"Int. J. Stroke"},{"key":"BFjhg201180_CR54","doi-asserted-by":"publisher","first-page":"515.e8-14","DOI":"10.1016\/j.urology.2010.04.035","volume":"76","author":"E Waldkirch","year":"2010","unstructured":"Waldkirch, E., \u00dcckert, S., Sigl, K., Langnaese, K., Richter, K., Stief, C. G. et al. Expression of cAMP-dependent protein kinase isoforms in the human prostate: functional significance and relation to PDE4. Urology 76, 515.e8-14 (2010).","journal-title":"Urology"},{"key":"BFjhg201180_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ng1245","volume":"35","author":"S Gretarsdottir","year":"2003","unstructured":"Gretarsdottir, S., Thorleifsson, G., Reynisdottir, S. T., Manolescu, A., Jonsdottir, S., Jonsdottir, T. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35, 131\u2013138 (2003).","journal-title":"Nat. Genet."},{"key":"BFjhg201180_CR56","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2174\/138945007781077355","volume":"8","author":"OA Ross","year":"2007","unstructured":"Ross, O. A., Worrall, B. B. & Meschia, J. F. Advancing stroke therapeutics through genetic understanding. Curr. Drug Targets 8, 850\u2013859 (2007).","journal-title":"Curr. Drug Targets"},{"key":"BFjhg201180_CR57","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ajhg.2009.04.001","volume":"84","author":"PJ Newcombe","year":"2009","unstructured":"Newcombe, P. J., Verzilli, C., Casas, J. P., Hingorani, A. D., Smeeth, L. & Whittaker, J. C. Multilocus Bayesian meta-analysis of gene-disease associations. Am. J. Hum. Genet. 84, 567\u2013580 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg201180_CR58","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1042\/CS20080162","volume":"116","author":"H Xue","year":"2009","unstructured":"Xue, H., Wang, H., Song, X., Li, W., Sun, K., Zhang, W. et al. Phosphodiesterase 4D gene polymorphism is associated with ischaemic and haemorrhagic stroke. Clin. Sci. 116, 335 (2009).","journal-title":"Clin. Sci."},{"key":"BFjhg201180_CR59","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/ejhg.2008.62","volume":"16","author":"H L\u00f6vkvist","year":"2008","unstructured":"L\u00f6vkvist, H., Smith, J. G., Luthman, H., H\u00f6glund, P., Norrving, B., Kristoffersson, U. et al. Ischaemic stroke in hypertensive patients is associated with variations in the PDE4D genome region. Eur. J. Hum. Genet. 16, 1117\u20131125 (2008).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFjhg201180_CR60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3346\/jkms.2009.24.2.307","volume":"24","author":"MK Kim","year":"2009","unstructured":"Kim, M. K., Kim, J. T., Choi, S. M., Lee, S. H., Park, M. S. & Cho, K. H. Phosphodiesterase4D gene and risk of noncardiogenic ischemic stroke in a Korean population. J. Korean Med. Sci. 24, 307\u2013310 (2009).","journal-title":"J. Korean Med. Sci."},{"key":"BFjhg201180_CR61","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1042\/CS20080471","volume":"117","author":"Y Sun","year":"2009","unstructured":"Sun, Y., Huang, Y., Chen, X., Liu, Y., Lu, X., Shi, Y. et al. Association between the PDE4D gene and ischaemic stroke in the Chinese Han population. Clin. Sci. 117, 265\u2013272 (2009).","journal-title":"Clin. Sci."},{"key":"BFjhg201180_CR62","first-page":"861","volume":"46","author":"EA Bondarenko","year":"2010","unstructured":"Bondarenko, E. A., Tupitsyna, T. V., Slominski, P. A., Shetova, I. M., Shamalov, N. A., Botsina, A. I. et al. [Phosphodiesterase 4D (PDE4D) gene polymorphism in patients with acute stroke from Moscow]. Genetika 46, 861\u2013864 (2010).","journal-title":"Genetika"},{"key":"BFjhg201180_CR63","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1161\/STROKEAHA.107.509992","volume":"39","author":"S Bevan","year":"2008","unstructured":"Bevan, S., Dichgans, M., Gschwendtner, A., Kuhlenb\u00e4umer, G., Ringelstein, E. B. & Markus, H. S. Variation in the PDE4D gene and ischemic stroke risk: a systematic review and meta-analysis on 5200 cases and 6600 controls. Stroke 39, 1966\u20131971 (2008).","journal-title":"Stroke"},{"key":"BFjhg201180_CR64","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1161\/STROKEAHA.108.527408","volume":"40","author":"T Matsushita","year":"2009","unstructured":"Matsushita, T., Kubo, M., Yonemoto, K., Ninomiya, T., Ashikawa, K., Liang, B. et al. Lack of association between variations of PDE4D and ischemic stroke in the Japanese population. Stroke 40, 1245\u20131251 (2009).","journal-title":"Stroke"},{"key":"BFjhg201180_CR65","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jns.2009.06.024","volume":"285","author":"A Munshi","year":"2009","unstructured":"Munshi, A., Babu, M. S., Kaul, S., Shafi, G., Anila, A. N., Alladi, S. et al. Phosphodiesterase 4D (PDE4D) gene variants and the risk of ischemic stroke in a South Indian population. J. Neurol. Sci. 285, 142\u2013145 (2009).","journal-title":"J. Neurol. Sci."},{"key":"BFjhg201180_CR66","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/ejhg.2009.71","volume":"17","author":"G Quarta","year":"2009","unstructured":"Quarta, G., Stanzione, R., Evangelista, A., Zanda, B., Di Angelantonio, E., Marchitti, S. et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in Sardinians. Eur. J. Hum. Genet. 17, 1448\u20131453 (2009).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFjhg201180_CR67","first-page":"933","volume":"18","author":"S Homma","year":"2006","unstructured":"Homma, S., Sakamoto, T., Hegab, A. E., Saitoh, W., Nomura, A., Ishii, Y. et al. Association of phosphodiesterase 4D gene polymorphisms with chronic obstructive pulmonary disease: relationship to interleukin 13 gene polymorphism. Int. J. Mol. Med. 18, 933\u2013939 (2006).","journal-title":"Int. J. Mol. Med."},{"key":"BFjhg201180_CR68","doi-asserted-by":"crossref","unstructured":"Gottlieb, D. J., O\u2019Connor, G. T. & Wilk, J. B. Genome-wide association of sleep and circadian phenotypes. BMC Med. Genet. (8 Suppl 1), S9 (2007).","DOI":"10.1186\/1471-2350-8-S1-S9"},{"key":"BFjhg201180_CR69","doi-asserted-by":"publisher","first-page":"e11504","DOI":"10.1371\/journal.pone.0011504","volume":"5","author":"FCF Calboli","year":"2010","unstructured":"Calboli, F. C. F., Tozzi, F., Galwey, N. W., Antoniades, A., Mooser, V., Preisig, M. et al. A genome-wide association study of neuroticism in a population-based sample. PloS One 5, e11504 (2010).","journal-title":"PloS One"},{"key":"BFjhg201180_CR70","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/mp.2008.2","volume":"13","author":"A Heck","year":"2008","unstructured":"Heck, A., Lieb, R., Unschuld, P. G., Ellgas, A., Pfister, H., Lucae, S. et al. Evidence for associations between PDE4D polymorphisms and a subtype of neuroticism. Mol. Psychiatry 13, 831\u2013832 (2008).","journal-title":"Mol. Psychiatry"},{"key":"BFjhg201180_CR71","first-page":"785","volume":"23","author":"T Yoshida","year":"2009","unstructured":"Yoshida, T., Kato, K., Yokoi, K., Oguri, M., Watanabe, S., Metoki, N. et al. Association of gene polymorphisms with chronic kidney disease in high- or low-risk subjects defined by conventional risk factors. Int. J. Mol. Med. 23, 785\u2013792 (2009).","journal-title":"Int. J. Mol. Med."},{"key":"BFjhg201180_CR72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1471-2350-11-93","volume":"11","author":"YC Liao","year":"2010","unstructured":"Liao, Y. C., Lin, H. F., Guo, Y. C., Yu, M. L., Liu, C. K. & Juo, S.- H. H. Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis. BMC Med. Genet. 11, 93 (2010).","journal-title":"BMC Med. Genet."},{"key":"BFjhg201180_CR73","doi-asserted-by":"publisher","first-page":"631.e1-8","DOI":"10.1016\/j.jaci.2010.06.030","volume":"126","author":"E Mel\u00e9n","year":"2010","unstructured":"Mel\u00e9n, E., Himes, B. E., Brehm, J. M., Boutaoui, N., Klanderman, B. J., Sylvia, J. S. et al. Analyses of shared genetic factors between asthma and obesity in children. J. Allergy Clin. Immunol. 126, 631.e1-8\u2013637.e1-8 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFjhg201180_CR74","first-page":"192","volume":"66","author":"L Bryniarski","year":"2009","unstructured":"Bryniarski, L., Rzepecki, M., Klocek, M. & Wyczo\u0142kowski, M. [The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease]. Przegl. Lek. 66, 192\u2013197 (2009).","journal-title":"Przegl. Lek."},{"key":"BFjhg201180_CR75","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1164\/rccm.200809-1472OC","volume":"179","author":"KE Roberts","year":"2009","unstructured":"Roberts, K. E., Fallon, M. B., Krowka, M. J., Brown, R. S., Trotter, J. F., Peter, I. et al. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am. J. Respir. Crit. Care Med. 179, 835\u2013842 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFjhg201180_CR76","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00467-010-1579-x","volume":"25","author":"W-H Hahn","year":"2010","unstructured":"Hahn, W- H, Suh, J- S & Cho, B- S Phosphodiesterase-5gene (PDE5A) polymorphisms are associated with progression of childhood IgA nephropathy. Pediatr. Nephrol. 25, 1663\u20131671 (2010).","journal-title":"Pediatr. Nephrol."},{"key":"BFjhg201180_CR77","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1399-0004.2010.01487.x","volume":"78","author":"M Corton","year":"2010","unstructured":"Corton, M., Blanco, M. J., Torres, M., Sanchez-Salorio, M., Carracedo, A. & Brion, M. Identification of a novel mutation in the human PDE6A gene in autosomal recessive retinitis pigmentosa: homology with the nmf28\/nmf28 mice model. Clin. Genet. 78, 495\u2013498 (2010).","journal-title":"Clin. Genet."},{"key":"BFjhg201180_CR78","first-page":"1283","volume":"12","author":"SA Riazuddin","year":"2006","unstructured":"Riazuddin, S. A., Zulfiqar, F., Zhang, Q., Yao, W., Li, S., Jiao, X. et al. Mutations in the gene encoding the alpha-subunit of rod phosphodiesterase in consanguineous Pakistani families. Mol. Vis. 12, 1283\u20131291 (2006).","journal-title":"Mol. Vis."},{"key":"BFjhg201180_CR79","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/ng0594-64","volume":"7","author":"A Gal","year":"1994","unstructured":"Gal, A., Orth, U., Baehr, W., Schwinger, E. & Rosenberg, T. Heterozygous missense mutation in the rod cGMP phosphodiesterase beta-subunit gene in autosomal dominant stationary night blindness. Nat. Genet. 7, 64\u201368 (1994).","journal-title":"Nat. Genet."},{"key":"BFjhg201180_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/geno.1995.0001","volume":"30","author":"M Danciger","year":"1995","unstructured":"Danciger, M., Blaney, J., Gao, Y. Q., Zhao, D. Y., Heckenlively, J. R., Jacobson, S. G. et al. Mutations in the PDE6B gene in autosomal recessive retinitis pigmentosa. Genomics 30, 1\u20137 (1995).","journal-title":"Genomics"},{"key":"BFjhg201180_CR81","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/hmg\/ddn327","volume":"18","author":"K Sakamoto","year":"2009","unstructured":"Sakamoto, K., McCluskey, M., Wensel, T. G., Naggert, J. K. & Nishina, P. M. New mouse models for recessive retinitis pigmentosa caused by mutations in the Pde6a gene. Hum. Mol. Genet. 18, 178\u2013192 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFjhg201180_CR82","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/ejhg.2008.167","volume":"17","author":"M Hmani-Aifa","year":"2008","unstructured":"Hmani-Aifa, M., Benzina, Z., Zulfiqar, F., Dhouib, H., Shahzadi, A., Ghorbel, A. et al. Identification of two new mutations in the GPR98 and the PDE6B genes segregating in a Tunisian family. Eur. J. Hum. Genet. 17, 474\u2013482 (2008).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFjhg201180_CR83","first-page":"1818","volume":"40","author":"YQ Gao","year":"1999","unstructured":"Gao, Y. Q., Danciger, M., Longmuir, R., Piriev, N. I., Zhao, D. Y., Heckenlively, J. R. et al. Screening of the gene encoding the alpha-subunit of cone cGMP-PDE in patients with retinal degenerations. Invest. Ophthalmol. Vis. Sci. 40, 1818\u20131822 (1999).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFjhg201180_CR84","first-page":"23","volume":"50","author":"DF Wyszynski","year":"2004","unstructured":"Wyszynski, D. F., Baldwin, C. T., Cleves, M. A., Amirault, Y., Nolan, V. G., Farrell, J. J. et al. Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia. Cell. Mol. Biol. 50, 23\u201333 (2004).","journal-title":"Cell. Mol. Biol."},{"key":"BFjhg201180_CR85","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/molehr\/gap035","volume":"15","author":"C Chen","year":"2009","unstructured":"Chen, C., Wickenheisser, J., Ewens, K. G., Ankener, W., Legro, R. S., Dunaif, A. et al. PDE8A genetic variation, polycystic ovary syndrome and androgen levels in women. Mol. Hum. Reprod. 15, 459\u2013469 (2009).","journal-title":"Mol. Hum. Reprod."},{"key":"BFjhg201180_CR86","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.ajhg.2008.04.019","volume":"82","author":"L Arnaud-Lopez","year":"2008","unstructured":"Arnaud-Lopez, L., Usala, G., Ceresini, G., Mitchell, B. D., Pilia, M. G., Piras, M. G. et al. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am. J. Hum. Genet. 82, 1270\u20131280 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"BFjhg201180_CR87","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1210\/jc.2009-1298","volume":"94","author":"BM Shields","year":"2009","unstructured":"Shields, B. M., Freathy, R. M., Knight, B. A., Hill, A., Weedon, M. N., Frayling, T. M. et al. Phosphodiesterase 8B gene polymorphism is associated with subclinical hypothyroidism in pregnancy. J. Clin. Endocrinol. Metab. 94, 4608\u20134612 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFjhg201180_CR88","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","volume":"14","author":"R Lib\u00e9","year":"2008","unstructured":"Lib\u00e9, R., Fratticci, A., Coste, J., Tissier, F., Horvath, A., Ragazzon, B. et al. Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clin. Cancer Res. 14, 4016\u20134024 (2008).","journal-title":"Clin. Cancer Res."},{"key":"BFjhg201180_CR89","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1158\/0008-5472.CAN-09-0884","volume":"69","author":"A Horvath","year":"2009","unstructured":"Horvath, A., Korde, L., Greene, M. H., Libe, R., Osorio, P., Faucz, F. R. et al. Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors. Cancer Res. 69, 5301\u20135306 (2009).","journal-title":"Cancer Res."},{"key":"BFjhg201180_CR90","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1530\/EJE-09-0677","volume":"161","author":"E Peverelli","year":"2009","unstructured":"Peverelli, E., Ermetici, F., Filopanti, M., Elli, F. M., Ronchi, C. L., Mantovani, G. et al. Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients. Eur. J. Endocrinol. 161, 687\u2013694 (2009).","journal-title":"Eur. J. Endocrinol."},{"key":"BFjhg201180_CR91","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jaci.2010.06.051","volume":"126","author":"AT DeWan","year":"2010","unstructured":"DeWan, A. T., Triche, E. W., Xu, X., Hsu, L.- I., Zhao, C., Belanger, K. et al. PDE11A associations with asthma: results of a genome-wide association scan. J. Allergy Clin. Immunol. 126, 871\u2013873.e9 (2010).","journal-title":"J. Allergy Clin. Immunol."}],"updated-by":[{"DOI":"10.1038\/jhg.2013.54","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T00:00:00Z","timestamp":1374710400000}}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhg201180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhg201180","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhg201180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T21:09:12Z","timestamp":1741381752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg201180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,28]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["BFjhg201180"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2011.80","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,28]]},"assertion":[{"value":"29 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}